Table 3 Medication overuse headache (MOH) incidence and prevalence values*
From: Migraine incidence in 5 years: a population-based prospective longitudinal study in Turkey
Age groups (years) | MOH incidence | MOH prevalence | OR (95 % CI) | ||||
|---|---|---|---|---|---|---|---|
(%) n = 2928 | (%) n = 502 | ||||||
Women | Men | Total | Women | Men | Total | ||
18–24 | 0.452 | 0.000 | 0.246 | 14.3 | 0.0 | 10.0 | 0.857 (0.692–1.062) |
25–29 | 0.313 | 0.177 | 0.239 | 5.0 | 4.3 | 4.8 | 0.864 (0.074–10.081) |
30–34 | 0.511 | 0.000 | 0.227 | 6.6 | 0.0 | 4.1 | 0.934 (0.874–0.999) |
35–39 | 0.454 | 0.260 | 0.344 | 5.0 | 8.6 | 6.7 | 1.781 (0.280–11.328) |
40–44 | 0.656 | 0.106 | 0.352 | 10.0 | 6.5 | 8.5 | 0.621 (0.106–3.631) |
45–49 | 0.111 | 0.114 | 0.113 | 4.3 | 3.7 | 4.1 | 0.865 (0.075–10.014) |
50–54 | 0.279 | 0.142 | 0.211 | 6.9 | 7.7 | 7.1 | 1.125 (0.093–13.636) |
55–59 | 0.890 | 0.162 | 0.509 | 26.3 | 0.0 | 15.6 | 0.737 (0.563–0.064) |
60–65 | 0.000 | 0.000 | 0.000 | 0.0 | 0.0 | 0.0 | |
65+ | 0.000 | 0.597 | 0.313 | 0.0 | 14.3 | 7.7 | 1.167 (0.862–1.579) |